Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 310 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1492. Clear
Clear
1A
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Tariff (miscellaneous tariff bills), Agriculture, Budget/Appropriations, Copyright/Patent/Trademark
View → 4A
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Natural Resources, Environment/Superfund, Labor Issues/Antitrust/Workplace, Foreign Relations
View → Q2
EMD SERONO, INC. for EMD SERONO INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues, Medicare/Medicaid
View → Q2
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Trade (domestic/foreign), Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View → Q2
BIOGEN for BIOGEN
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View → Q2
BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q2
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Agriculture, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View → Q2
DLA PIPER LLP (US) for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues
View → Q2
AMGEN, INC. for AMGEN INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q2
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Defense, Health Issues, Budget/Appropriations, Copyright/Patent/Trademark
View → Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Pharmacy, Trade (domestic/foreign), Financial Institutions/Investments/Securities, Health Issues
View → Q2
WILLIAMS AND JENSEN, PLLC for PHRMA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Budget/Appropriations, Defense, Trade (domestic/foreign), Medicare/Medicaid
View → Q2
NATIONAL ALLIANCE ON MENTAL ILLNESS for NATIONAL ALLIANCE ON MENTAL ILLNESS
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Health Issues, Budget/Appropriations, Law Enforcement/Crime/Criminal Justice, Education
View → Q2
MONUMENT ADVOCACY for PHRMA
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $90,000.00 income
Trade (domestic/foreign), Foreign Relations, Health Issues
View → Q2
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Animals
View → Q2
THE ALS ASSOCIATION for THE ALS ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Welfare, Aviation/Airlines/Airports, Small Business, Budget/Appropriations
View → Q2
AVENUE SOLUTIONS for GENENTECH USA, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View → Q2
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View → Q2
PUBLIC CITIZEN for PUBLIC CITIZEN
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Consumer Issues/Safety/Products, Financial Institutions/Investments/Securities, Banking, Civil Rights/Civil Liberties
View → Q2
THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View → Q2
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View → Q2
THE MCMANUS GROUP for GILEAD SCIENCES, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View → Q2
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Page 1 of 13 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem